Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement

Adrian Minsona Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Victoria, Australia;b Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, AustraliaCorrespondence[email protected]
View further author information

Michael Dickinsona Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Victoria, Australia;b Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, AustraliaView further author information

"Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement." Leukemia & Lymphoma, 65(5), pp. 546–547

View correction statement:

Correction

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article was originally published with errors, which have now been corrected in the online version. Please see Correction (http://dx.doi.org/10.1080/10428194.2024.2339091)

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement

Information for

Open access

Opportunities

Help and information

Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement

Disclosure statement

Correction Statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature